These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 12373774)
1. Bronchoalveolar lavage fluid protein composition in patients with sarcoidosis and idiopathic pulmonary fibrosis: a two-dimensional electrophoretic study. Magi B; Bini L; Perari MG; Fossi A; Sanchez JC; Hochstrasser D; Paesano S; Raggiaschi R; Santucci A; Pallini V; Rottoli P Electrophoresis; 2002 Sep; 23(19):3434-44. PubMed ID: 12373774 [TBL] [Abstract][Full Text] [Related]
2. Human bronchoalveolar lavage fluid protein two-dimensional database: study of interstitial lung diseases. Wattiez R; Hermans C; Cruyt C; Bernard A; Falmagne P Electrophoresis; 2000 Jul; 21(13):2703-12. PubMed ID: 10949149 [TBL] [Abstract][Full Text] [Related]
3. Carbonylated proteins in bronchoalveolar lavage of patients with sarcoidosis, pulmonary fibrosis associated with systemic sclerosis and idiopathic pulmonary fibrosis. Rottoli P; Magi B; Cianti R; Bargagli E; Vagaggini C; Nikiforakis N; Pallini V; Bini L Proteomics; 2005 Jul; 5(10):2612-8. PubMed ID: 15924291 [TBL] [Abstract][Full Text] [Related]
4. Protein profile in bronchoalveolar lavage fluid from patients with sarcoidosis and idiopathic pulmonary fibrosis as revealed by SDS-PAGE electrophoresis and western blot analysis. Uebelhoer M; Bewig B; Oldigs M; Nowak D; Magnussen H; Petermann W; Barth J Scand J Clin Lab Invest; 1993 Oct; 53(6):617-23. PubMed ID: 8266009 [TBL] [Abstract][Full Text] [Related]
6. Analysis of bronchoalveolar lavage fluid proteome from systemic sclerosis patients with or without functional, clinical and radiological signs of lung fibrosis. Fietta A; Bardoni A; Salvini R; Passadore I; Morosini M; Cavagna L; Codullo V; Pozzi E; Meloni F; Montecucco C Arthritis Res Ther; 2006; 8(6):R160. PubMed ID: 17044913 [TBL] [Abstract][Full Text] [Related]
7. [Extracellular components of bronchoalveolar lavage fluid (BALF) as a marker of interstitial pulmonary disease activity. I. Protein concentration]. Zielonka TM; Wałajtys-Rode E; Chazan R; Droszcz W Przegl Lek; 1998; 55(11):581-5. PubMed ID: 10216371 [TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor in bronchoalveolar lavage from normal subjects and patients with diffuse parenchymal lung disease. Meyer KC; Cardoni A; Xiang ZZ J Lab Clin Med; 2000 Apr; 135(4):332-8. PubMed ID: 10779049 [TBL] [Abstract][Full Text] [Related]
9. [Extracellular components of bronchoalveolar lavage fluid (BALF) as a marker of the activity of interstitial pulmonary diseases. III: Phospholipids to protein concentration ratio]. Zielonka TM; Wałajtys-Rode E; Jasińska R; Chazan R; Droszcz W Przegl Lek; 1999; 56(2):144-7. PubMed ID: 10375948 [TBL] [Abstract][Full Text] [Related]
10. Levels of cytokeratin 19 fragments in bronchoalveolar lavage fluid correlate to the intensity of neutrophil and eosinophil-alveolitis in patients with idiopathic pulmonary fibrosis. Inage M; Nakamura H; Kato S; Saito H; Abe S; Hino T; Tomoike H Respir Med; 2000 Feb; 94(2):155-60. PubMed ID: 10714422 [TBL] [Abstract][Full Text] [Related]
11. [A study on enzymatic activities of bronchoalveolar lavage fluid in patients with interstitial lung diseases]. Zheng J; Jia Y; Zhou K Zhonghua Jie He He Hu Xi Za Zhi; 1998 Feb; 21(2):91-3. PubMed ID: 11263392 [TBL] [Abstract][Full Text] [Related]
12. Proteomic study of human bronchoalveolar lavage fluids from smokers with chronic obstructive pulmonary disease by combining surface-enhanced laser desorption/ionization-mass spectrometry profiling with mass spectrometric protein identification. Merkel D; Rist W; Seither P; Weith A; Lenter MC Proteomics; 2005 Jul; 5(11):2972-80. PubMed ID: 16075419 [TBL] [Abstract][Full Text] [Related]
13. Comparison of BALF concentrations of ENA-78 and IP10 in patients with idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia. Nakayama S; Mukae H; Ishii H; Kakugawa T; Sugiyama K; Sakamoto N; Fujii T; Kadota J; Kohno S Respir Med; 2005 Sep; 99(9):1145-51. PubMed ID: 16085216 [TBL] [Abstract][Full Text] [Related]
14. Human bronchoalveolar lavage fluid: two-dimensional gel electrophoresis, amino acid microsequencing and identification of major proteins. Wattiez R; Hermans C; Bernard A; Lesur O; Falmagne P Electrophoresis; 1999 Jun; 20(7):1634-45. PubMed ID: 10424490 [TBL] [Abstract][Full Text] [Related]
15. [Extracellular components of broncho-alveolar lavage fluid (BALF) as markers of interstitial pulmonary disease activity. II. Phospholipid concentration]. Zielonka TM; Wałajtys-Rode E; Jasińska R; Chazan R; Droszcz W Przegl Lek; 1998; 55(12):654-8. PubMed ID: 10354716 [TBL] [Abstract][Full Text] [Related]
16. Bronchoalveolar lavage fluid cellular characteristics, functional parameters and cytokine and chemokine levels in interstitial lung diseases. Vasakova M; Sterclova M; Kolesar L; Slavcev A; Pohunek P; Sulc J; Skibova J; Striz I Scand J Immunol; 2009 Mar; 69(3):268-74. PubMed ID: 19281539 [TBL] [Abstract][Full Text] [Related]
17. Nitric oxide derivative in bronchoalveolar lavage fluid from patients with idiopathic pulmonary fibrosis. Behera D; Kaur S; Sathyanarayana G; Bhatnagar A; Majumdar S Indian J Chest Dis Allied Sci; 2002; 44(1):21-4. PubMed ID: 11845929 [TBL] [Abstract][Full Text] [Related]
18. Surfactant protein-A in lung lavage fluid obtained from patients with idiopathic pulmonary fibrosis. Behera D; Kaur S; Sathyanarayana G; Majumdar S J Assoc Physicians India; 2002 Nov; 50():1409-12. PubMed ID: 12583473 [TBL] [Abstract][Full Text] [Related]
19. Sialidase activity and antibodies to sialidase-treated autologous erythrocytes in bronchoalveolar lavages from patients with idiopathic pulmonary fibrosis or sarcoidosis. Lambré CR; Pilatte Y; Le Maho S; Greffard A; De Crémoux H; Bignon J Clin Exp Immunol; 1988 Aug; 73(2):230-5. PubMed ID: 3180512 [TBL] [Abstract][Full Text] [Related]
20. Elevated matrilysin levels in bronchoalveolar lavage fluid do not distinguish idiopathic pulmonary fibrosis from other interstitial lung diseases. Vuorinen K; Myllärniemi M; Lammi L; Piirilä P; Rytilä P; Salmenkivi K; Kinnula VL APMIS; 2007 Aug; 115(8):969-75. PubMed ID: 17696954 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]